RACGAP1 and hepatocellular carcinoma: Regarding the latter, the involvement of E-cadherin could be investigated, given its ability in binding and sequestering β-catenin from the nuclear signaling pool and experiments reporting that the inhibition of RacGAP1 in HCC cells and xenograft tumors resulted in an enhanced expression of E-cadherin [38,39].